Menu
Search
|

Menu

Close
X

OPKO Health Inc OPK.OQ (NASDAQ Stock Exchange Global Select Market)

3.59 USD
-0.08 (-2.18%)
As of Oct 19
chart
Previous Close 3.67
Open 3.63
Volume 898,851
3m Avg Volume 1,675,826
Today’s High 3.82
Today’s Low 3.55
52 Week High 6.99
52 Week Low 2.66
Shares Outstanding (mil) 559.77
Market Capitalization (mil) 2,054.36
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.33 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
519
FY17
1,016
FY16
1,222
FY15
492
EPS (USD)
FY18
-0.088
FY17
-0.557
FY16
-0.046
FY15
-0.101
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.14
Price to Sales (TTM)
vs sector
2.11
6.55
Price to Book (MRQ)
vs sector
1.13
4.00
Price to Cash Flow (TTM)
vs sector
--
21.51
Total Debt to Equity (MRQ)
vs sector
11.59
14.15
LT Debt to Equity (MRQ)
vs sector
9.38
11.31
Return on Investment (TTM)
vs sector
-12.45
12.83
Return on Equity (TTM)
vs sector
-15.81
14.95

EXECUTIVE LEADERSHIP

Phillip Frost
Chairman of the Board, Chief Executive Officer, Since 2007
Salary: $960,000.00
Bonus: --
Jane Hsiao
Vice Chairman of the Board, Chief Technical Officer, Since 2007
Salary: $900,000.00
Bonus: --
Adam Logal
Chief Financial Officer, Senior Vice President, Since 2014
Salary: $600,000.00
Bonus: --
Steven Rubin
Executive Vice President - Administration, Director, Since 2007
Salary: $810,000.00
Bonus: --
Robert Fishel
Independent Director, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

4400 Biscayne Blvd
MIAMI   FL   33137-3212

Phone: +1305.5754138
Site: www.opko.com

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.

SPONSORED STORIES